Erik C. Emerson Apimeds Pharmaceuticals Us, Inc. (APUS) insider trading activity

APUS Quotes by TradingView
Shares Held (Direct Ownership) 750K
n/a 3M change
n/a 12M change
Total Value Held N/A

Erik C. Emerson Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2025
BUY
Grant, award, or other acquisition
-
750,000 Added 50.0%
750,000 Common Stock, par valu...

Also insider at

ODYY
Odyssey Health, Inc. Healthcare
ECE

Erik C. Emerson

Chief Executive Officer
Las Vegas, NV

Track Institutional and Insider Activities on APUS

Follow Apimeds Pharmaceuticals US, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APUS shares.

Notify only if

Insider Trading

Get notified when an Apimeds Pharmaceuticals Us, Inc. insider buys or sells APUS shares.

Notify only if

News

Receive news related to Apimeds Pharmaceuticals US, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APUS